GILEAD SCIENCES, INC. Repayments of Long-Term Debt
GILEAD SCIENCES, INC. (GILD) reported Repayments of Long-Term Debt of $4.75 billion for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2022-02-23
- GILEAD SCIENCES, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $1.00B.
- GILEAD SCIENCES, INC. repayments of long-term debt for the quarter ending 2021-09-30 was $2.50B.
- GILEAD SCIENCES, INC. repayments of long-term debt for the quarter ending 2021-06-30 was $0.00.
- GILEAD SCIENCES, INC. repayments of long-term debt for the quarter ending 2021-03-31 was $1.25B.
- GILEAD SCIENCES, INC. repayments of long-term debt for fiscal 2021 was $4.75B.
- GILEAD SCIENCES, INC. repayments of long-term debt for fiscal 2011 was $649.99M.
- GILEAD SCIENCES, INC. repayments of long-term debt for fiscal 2010 was $0.00, a 100.00% decline from fiscal 2009.
- GILEAD SCIENCES, INC. repayments of long-term debt for fiscal 2009 was $305.45M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.50B derived: sum of 2 quarters · filed 2022-02-23 | $3.50B derived: sum of 3 quarters · filed 2022-02-23 | $4.75B 10-K · filed 2022-02-23 |
| 2021-09-30 | $2.50B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.50B derived: sum of 2 quarters · filed 2021-11-03 | $3.75B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.25B 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $1.25B 10-Q · filed 2021-05-06 | |||
| 2011-12-31 | $649.99M 10-K · filed 2012-02-23 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $0.00 10-K · filed 2012-02-23 | ||
| 2010-09-30 | $0.00 10-Q · filed 2010-11-08 | |||
| 2009-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $72.00K derived: sum of 2 quarters · filed 2012-02-23 | $305.45M 10-K · filed 2012-02-23 | |
| 2009-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $305.41M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | $305.38M 10-Q · filed 2010-08-09 | |||
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2010-03-01 | $0.00 derived: sum of 2 quarters · filed 2010-03-01 | $0.00 10-K · filed 2010-03-01 | |
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $0.00 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | $0.00 10-Q · filed 2009-08-05 | |||
| 2007-12-31 | $0.00 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |